Role of thrombophilia testing: con

go back to reference Galanaud JP, Laroche JP, Righini M (2013) The history and historical treatments of deep vein thrombosis. J Thromb Haemost 11(3):402–411. doi:10.1111/jth.12127 CrossRefPubMed Galanaud JP, Laroche JP, Righini M (2013) The history and historical treatments of deep vein thrombosis. J Thromb Haemost 11(3):402–411. doi:10.​1111/​jth.​12127 CrossRefPubMed

go back to reference Virchow R (1856) Gesammalte Abhandlungen zur Wissenschaftlichen Medtzin. Medinger Sohn, Frankfurt Virchow R (1856) Gesammalte Abhandlungen zur Wissenschaftlichen Medtzin. Medinger Sohn, Frankfurt

go back to reference Egeberg O (1965) Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 13:516–530PubMed Egeberg O (1965) Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 13:516–530PubMed

go back to reference Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C (1981) Deficiency of protein C in congenital thrombotic disease. J Clin Investig 68(5):1370–1373CrossRefPubMedCentralPubMed Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C (1981) Deficiency of protein C in congenital thrombotic disease. J Clin Investig 68(5):1370–1373CrossRefPubMedCentralPubMed

go back to reference Comp PC, Esmon CT (1984) Recurrent venous thromboembolism in patients with a partial deficiency of protein S. New Engl J Med 311(24):1525–1528. doi:10.1056/NEJM198412133112401 CrossRefPubMed Comp PC, Esmon CT (1984) Recurrent venous thromboembolism in patients with a partial deficiency of protein S. New Engl J Med 311(24):1525–1528. doi:10.​1056/​NEJM198412133112​401 CrossRefPubMed

go back to reference Dahlback B, Hildebrand B (1994) Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA 91(4):1396–1400CrossRefPubMedCentralPubMed Dahlback B, Hildebrand B (1994) Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA 91(4):1396–1400CrossRefPubMedCentralPubMed

go back to reference Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88(10):3698–3703PubMed Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88(10):3698–3703PubMed

go back to reference Nicolaides A, Hull RD, Fareed J (2013) Thrombophilia. Clin Appl Thromb Hemost 19(2):177–187. doi:10.1177/1076029612474840m Nicolaides A, Hull RD, Fareed J (2013) Thrombophilia. Clin Appl Thromb Hemost 19(2):177–187. doi:10.​1177/​1076029612474840​m

go back to reference Reitsma PH, Rosendaal FR (2007) Past and future of genetic research in thrombosis. J Thromb Haemost 5(Suppl 1):264–269. doi:10.1111/j.1538-7836.2007.02502.x CrossRefPubMed Reitsma PH, Rosendaal FR (2007) Past and future of genetic research in thrombosis. J Thromb Haemost 5(Suppl 1):264–269. doi:10.​1111/​j.​1538-7836.​2007.​02502.​x CrossRefPubMed

go back to reference Gohil R, Peck G, Sharma P (2009) The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls. Thromb Haemost 102(2):360–370. doi:10.1160/TH09-01-0013 PubMed Gohil R, Peck G, Sharma P (2009) The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls. Thromb Haemost 102(2):360–370. doi:10.​1160/​TH09-01-0013 PubMed

go back to reference De Stefano V, Rossi E (2013) Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups. Thromb Haemost 110(4):697–705. doi:10.1160/TH13-01-0011 CrossRefPubMed De Stefano V, Rossi E (2013) Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups. Thromb Haemost 110(4):697–705. doi:10.​1160/​TH13-01-0011 CrossRefPubMed

go back to reference Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR (2012) Antithrombotic therapy for VTE disease. Chest 141(2 suppl):e419S–e494S. doi:10.1378/chest.11-2301 PubMedCentralPubMed Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR (2012) Antithrombotic therapy for VTE disease. Chest 141(2 suppl):e419S–e494S. doi:10.​1378/​chest.​11-2301 PubMedCentralPubMed

go back to reference National Institute for Health and Clinical Excellence: Guidance (2012) In: Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing. London, National Institute for Health and Clinical Excellence: Guidance National Institute for Health and Clinical Excellence: Guidance (2012) In: Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing. London, National Institute for Health and Clinical Excellence: Guidance

go back to reference Evaluation of Genomic Applications in P, Prevention Working G (2011) Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members. Genet Med 13(1):67–76. doi:10.1097/GIM.0b013e3181fbe46f Evaluation of Genomic Applications in P, Prevention Working G (2011) Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members. Genet Med 13(1):67–76. doi:10.​1097/​GIM.​0b013e3181fbe46f​

go back to reference Pernod G, Biron-Andreani C, Morange PE, Boehlen F, Constans J, Couturaud F, Drouet L, Jude B, Lecompte T, Le Gal G, Trillot N, Wahl D, French group on h, thrombosis, French Society of vascular m (2009) Recommendations on testing for thrombophilia in venous thromboembolic disease: a French consensus guideline. J Mal Vasc 34(3):156–203CrossRefPubMed Pernod G, Biron-Andreani C, Morange PE, Boehlen F, Constans J, Couturaud F, Drouet L, Jude B, Lecompte T, Le Gal G, Trillot N, Wahl D, French group on h, thrombosis, French Society of vascular m (2009) Recommendations on testing for thrombophilia in venous thromboembolic disease: a French consensus guideline. J Mal Vasc 34(3):156–203CrossRefPubMed

go back to reference Dalen JE (2008) Should patients with venous thromboembolism be screened for thrombophilia? Am J Med 121(6):458–463. doi:10.1016/j.amjmed.2007.10.042 CrossRefPubMed Dalen JE (2008) Should patients with venous thromboembolism be screened for thrombophilia? Am J Med 121(6):458–463. doi:10.​1016/​j.​amjmed.​2007.​10.​042 CrossRefPubMed

go back to reference Foy P, Moll S (2009) Thrombophilia: 2009 update. Current Treat Options Cardiovasc Med 11(2):114–128CrossRef Foy P, Moll S (2009) Thrombophilia: 2009 update. Current Treat Options Cardiovasc Med 11(2):114–128CrossRef

go back to reference Ho WK, Hankey GJ, Quinlan DJ, Eikelboom JW (2006) Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review. Arch Intern Med 166(7):729–736. doi:10.1001/archinte.166.7.729 CrossRefPubMed Ho WK, Hankey GJ, Quinlan DJ, Eikelboom JW (2006) Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review. Arch Intern Med 166(7):729–736. doi:10.​1001/​archinte.​166.​7.​729 CrossRefPubMed

go back to reference Kearon C, Akl EA (2014) Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism. Blood 123(12):1794–1801. doi:10.1182/blood-2013-12-512681 CrossRefPubMed Kearon C, Akl EA (2014) Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism. Blood 123(12):1794–1801. doi:10.​1182/​blood-2013-12-512681 CrossRefPubMed

go back to reference Lindhoff-Last E, Luxembourg B (2008) Evidence-based indications for thrombophilia screening. VASA Zeitschrift fur Gefasskrankheiten 37(1):19–30CrossRefPubMed Lindhoff-Last E, Luxembourg B (2008) Evidence-based indications for thrombophilia screening. VASA Zeitschrift fur Gefasskrankheiten 37(1):19–30CrossRefPubMed

go back to reference Merriman L, Greaves M (2006) Testing for thrombophilia: an evidence-based approach. Postgrad Med J 82(973):699–704. doi:10.1136/pgmj.2006.048090 CrossRefPubMedCentralPubMed Merriman L, Greaves M (2006) Testing for thrombophilia: an evidence-based approach. Postgrad Med J 82(973):699–704. doi:10.​1136/​pgmj.​2006.​048090 CrossRefPubMedCentralPubMed

go back to reference Middeldorp S (2011) Evidence-based approach to thrombophilia testing. J Thromb Thrombolysis 31(3):275–281. doi:10.1007/s11239-011-0572-y CrossRefPubMedCentralPubMed Middeldorp S (2011) Evidence-based approach to thrombophilia testing. J Thromb Thrombolysis 31(3):275–281. doi:10.​1007/​s11239-011-0572-y CrossRefPubMedCentralPubMed

go back to reference Middeldorp S, van Hylckama VA (2008) Does thrombophilia testing help in the clinical management of patients? Br J Haematol 143(3):321–335. doi:10.1111/j.1365-2141.2008.07339.x CrossRefPubMed Middeldorp S, van Hylckama VA (2008) Does thrombophilia testing help in the clinical management of patients? Br J Haematol 143(3):321–335. doi:10.​1111/​j.​1365-2141.​2008.​07339.​x CrossRefPubMed

go back to reference Moll S (2011) Who should be tested for thrombophilia? Genet Med 13(1):19–20. doi:10.1097/GIM.0b013e3182088189 CrossRefPubMed Moll S (2011) Who should be tested for thrombophilia? Genet Med 13(1):19–20. doi:10.​1097/​GIM.​0b013e3182088189​ CrossRefPubMed

go back to reference Prandoni P, Barbar S, Milan M, Campello E, Spiezia L, Piovella C, Pesavento R (2014) Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests. Thromb Haemost. doi:10.1160/TH14-04-0396 Prandoni P, Barbar S, Milan M, Campello E, Spiezia L, Piovella C, Pesavento R (2014) Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests. Thromb Haemost. doi:10.​1160/​TH14-04-0396

go back to reference Stegnar M (2010) Thrombophilia screening—at the right time, for the right patient, with a good reason. Clinical chemistry and laboratory medicine : CCLM/FESCC 48(Suppl 1):S105–113. doi:10.1515/CCLM.2010.367 Stegnar M (2010) Thrombophilia screening—at the right time, for the right patient, with a good reason. Clinical chemistry and laboratory medicine : CCLM/FESCC 48(Suppl 1):S105–113. doi:10.​1515/​CCLM.​2010.​367

go back to reference Van Cott EM, Laposata M, Prins MH (2002) Laboratory evaluation of hypercoagulability with venous or arterial thrombosis. Arch Pathol Lab Med 126(11):1281–1295. doi:10.1043/0003-9985(2002) PubMed Van Cott EM, Laposata M, Prins MH (2002) Laboratory evaluation of hypercoagulability with venous or arterial thrombosis. Arch Pathol Lab Med 126(11):1281–1295. doi:10.​1043/​0003-9985(2002) PubMed

go back to reference Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M, Walker ID, Langhorne P, Brenkel I, Regan L, Greer I (2006) Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess 10(11):1–110CrossRefPubMed Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M, Walker ID, Langhorne P, Brenkel I, Regan L, Greer I (2006) Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess 10(11):1–110CrossRefPubMed

go back to reference Heit JA (2008) The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol 28(3):370–372. doi:10.1161/ATVBAHA.108.162545 CrossRefPubMedCentralPubMed Heit JA (2008) The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol 28(3):370–372. doi:10.​1161/​ATVBAHA.​108.​162545 CrossRefPubMedCentralPubMed

go back to reference Deitelzweig SB, Johnson BH, Lin J, Schulman KL (2011) Prevalence of clinical venous thromboembolism in the USA: current trends and future projections. Am J Hematol 86(2):217–220. doi:10.1002/ajh.21917 CrossRefPubMed Deitelzweig SB, Johnson BH, Lin J, Schulman KL (2011) Prevalence of clinical venous thromboembolism in the USA: current trends and future projections. Am J Hematol 86(2):217–220. doi:10.​1002/​ajh.​21917 CrossRefPubMed

go back to reference Grody WW, Griffin JH, Taylor AK, Korf BR, Heit JA, Group AFVLW (2001) American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genet Med 3(2):139–148. doi:10.1097/00125817-200103000-00009 CrossRefPubMedCentralPubMed Grody WW, Griffin JH, Taylor AK, Korf BR, Heit JA, Group AFVLW (2001) American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genet Med 3(2):139–148. doi:10.​1097/​00125817-200103000-00009 CrossRefPubMedCentralPubMed

go back to reference Jordan FL, Nandorff A (1956) The familial tendency in thrombo-embolic disease. Acta Medica Scandinavica 156(4):267–275CrossRefPubMed Jordan FL, Nandorff A (1956) The familial tendency in thrombo-embolic disease. Acta Medica Scandinavica 156(4):267–275CrossRefPubMed

go back to reference Oger E, Lacut K, Le Gal G, Couturaud F, Guenet D, Abalain JH, Roguedas AM, Mottier D, Edith Collaborative Study G (2006) Hyperhomocysteinemia and low B vitamin levels are independently associated with venous thromboembolism: results from the EDITH study: a hospital-based case-control study. J Thromb Haemost 4(4):793–799. doi:10.1111/j.1538-7836.2006.01856.x CrossRefPubMed Oger E, Lacut K, Le Gal G, Couturaud F, Guenet D, Abalain JH, Roguedas AM, Mottier D, Edith Collaborative Study G (2006) Hyperhomocysteinemia and low B vitamin levels are independently associated with venous thromboembolism: results from the EDITH study: a hospital-based case-control study. J Thromb Haemost 4(4):793–799. doi:10.​1111/​j.​1538-7836.​2006.​01856.​x CrossRefPubMed

go back to reference Jick H, Slone D, Westerholm B, Inman WH, Vessey MP, Shapiro S, Lewis GP, Worcester J (1969) Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet 1(7594):539–542CrossRefPubMed Jick H, Slone D, Westerholm B, Inman WH, Vessey MP, Shapiro S, Lewis GP, Worcester J (1969) Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet 1(7594):539–542CrossRefPubMed

go back to reference Zhou S, Welsby I (2014) Is ABO blood group truly a risk factor for thrombosis and adverse outcomes? World J Cardiol 6(9):985–992. doi:10.4330/wjc.v6.i9.985 CrossRefPubMedCentralPubMed Zhou S, Welsby I (2014) Is ABO blood group truly a risk factor for thrombosis and adverse outcomes? World J Cardiol 6(9):985–992. doi:10.​4330/​wjc.​v6.​i9.​985 CrossRefPubMedCentralPubMed

go back to reference Rodger MA, Hague WM, Kingdom J, Kahn SR, Karovitch A, Sermer M, Clement AM, Coat S, Chan WS, Said J, Rey E, Robinson S, Khurana R, Demers C, Kovacs MJ, Solymoss S, Hinshaw K, Dwyer J, Smith G, McDonald S, Newstead-Angel J, McLeod A, Khandelwal M, Silver RM, Le Gal G, Greer IA, Keely E, Rosene-Montella K, Walker M, Wells PS, Investigators T (2014) Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial. Lancet 384(9955):1673–1683. doi:10.1016/S0140-6736(14)60793-5 CrossRefPubMed Rodger MA, Hague WM, Kingdom J, Kahn SR, Karovitch A, Sermer M, Clement AM, Coat S, Chan WS, Said J, Rey E, Robinson S, Khurana R, Demers C, Kovacs MJ, Solymoss S, Hinshaw K, Dwyer J, Smith G, McDonald S, Newstead-Angel J, McLeod A, Khandelwal M, Silver RM, Le Gal G, Greer IA, Keely E, Rosene-Montella K, Walker M, Wells PS, Investigators T (2014) Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial. Lancet 384(9955):1673–1683. doi:10.​1016/​S0140-6736(14)60793-5 CrossRefPubMed

go back to reference Lutsey PL, Cushman M, Heckbert SR, Tang W, Folsom AR (2011) Longer legs are associated with greater risk of incident venous thromboembolism independent of total body height. The longitudinal study of thromboembolism etiology (LITE). Thromb Haemost 106(1):113–120. doi:10.1160/TH11-02-0100 CrossRefPubMedCentralPubMed Lutsey PL, Cushman M, Heckbert SR, Tang W, Folsom AR (2011) Longer legs are associated with greater risk of incident venous thromboembolism independent of total body height. The longitudinal study of thromboembolism etiology (LITE). Thromb Haemost 106(1):113–120. doi:10.​1160/​TH11-02-0100 CrossRefPubMedCentralPubMed

go back to reference Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR (2005) Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 293(19):2352–2361. doi:10.1001/jama.293.19.2352 CrossRefPubMed Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR (2005) Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 293(19):2352–2361. doi:10.​1001/​jama.​293.​19.​2352 CrossRefPubMed

go back to reference Baglin T, Luddington R, Brown K, Baglin C (2003) Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 362(9383):523–526. doi:10.1016/S0140-6736(03)14111-6 CrossRefPubMed Baglin T, Luddington R, Brown K, Baglin C (2003) Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 362(9383):523–526. doi:10.​1016/​S0140-6736(03)14111-6 CrossRefPubMed

go back to reference Simone B, De Stefano V, Leoncini E, Zacho J, Martinelli I, Emmerich J, Rossi E, Folsom AR, Almawi WY, Scarabin PY, den Heijer M, Cushman M, Penco S, Vaya A, Angchaisuksiri P, Okumus G, Gemmati D, Cima S, Akar N, Oguzulgen KI, Ducros V, Lichy C, Fernandez-Miranda C, Szczeklik A, Nieto JA, Torres JD, Le Cam-Duchez V, Ivanov P, Cantu-Brito C, Shmeleva VM, Stegnar M, Ogunyemi D, Eid SS, Nicolotti N, De Feo E, Ricciardi W, Boccia S (2013) Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol 28(8):621–647. doi:10.1007/s10654-013-9825-8 CrossRefPubMedCentralPubMed Simone B, De Stefano V, Leoncini E, Zacho J, Martinelli I, Emmerich J, Rossi E, Folsom AR, Almawi WY, Scarabin PY, den Heijer M, Cushman M, Penco S, Vaya A, Angchaisuksiri P, Okumus G, Gemmati D, Cima S, Akar N, Oguzulgen KI, Ducros V, Lichy C, Fernandez-Miranda C, Szczeklik A, Nieto JA, Torres JD, Le Cam-Duchez V, Ivanov P, Cantu-Brito C, Shmeleva VM, Stegnar M, Ogunyemi D, Eid SS, Nicolotti N, De Feo E, Ricciardi W, Boccia S (2013) Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol 28(8):621–647. doi:10.​1007/​s10654-013-9825-8 CrossRefPubMedCentralPubMed

go back to reference Coppens M, Reijnders JH, Middeldorp S, Doggen CJ, Rosendaal FR (2008) Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosis. J Thromb Haemost 6(9):1474–1477. doi:10.1111/j.1538-7836.2008.03055.x CrossRefPubMed Coppens M, Reijnders JH, Middeldorp S, Doggen CJ, Rosendaal FR (2008) Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosis. J Thromb Haemost 6(9):1474–1477. doi:10.​1111/​j.​1538-7836.​2008.​03055.​x CrossRefPubMed

go back to reference Hicks LK, Bering H, Carson KR, Kleinerman J, Kukreti V, Ma A, Mueller BU, O’Brien SH, Pasquini M, Sarode R, Solberg L Jr, Haynes AE, Crowther MA (2013) The ASH Choosing Wisely(R)campaign: five hematologic tests and treatments to question. Hematology 2013:9–14. doi:10.1182/asheducation-2013.1.9 CrossRefPubMed Hicks LK, Bering H, Carson KR, Kleinerman J, Kukreti V, Ma A, Mueller BU, O’Brien SH, Pasquini M, Sarode R, Solberg L Jr, Haynes AE, Crowther MA (2013) The ASH Choosing Wisely(R)campaign: five hematologic tests and treatments to question. Hematology 2013:9–14. doi:10.​1182/​asheducation-2013.​1.​9 CrossRefPubMed

go back to reference Medicine SfV Choosing Wisely. Society for Vascular Medicine (2014) Five things physicians and pateints should question. http://www.vascularmed.org/choosing/SVMCWList.pdf. Accessed 20 Nov 2014 Medicine SfV Choosing Wisely. Society for Vascular Medicine (2014) Five things physicians and pateints should question. http://​www.​vascularmed.​org/​choosing/​SVMCWList.​pdf. Accessed 20 Nov 2014

go back to reference Foundation ABoIM (2014) Choosing Wisely. http://www.choosingwisely.org/. Accessed 29 Nov 2014 Foundation ABoIM (2014) Choosing Wisely. http://​www.​choosingwisely.​org/​. Accessed 29 Nov 2014

go back to reference Boutitie F, Pinede L, Schulman S, Agnelli G, Raskob G, Julian J, Hirsh J, Kearon C (2011) Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants’ data from seven trials. BMJ 342:d3036. doi:10.1136/bmj.d3036 CrossRefPubMedCentralPubMed Boutitie F, Pinede L, Schulman S, Agnelli G, Raskob G, Julian J, Hirsh J, Kearon C (2011) Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants’ data from seven trials. BMJ 342:d3036. doi:10.​1136/​bmj.​d3036 CrossRefPubMedCentralPubMed

go back to reference Garcia D, Akl EA, Carr R, Kearon C (2013) Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review. Blood 122(5):817–824. doi:10.1182/blood-2013-04-496257 CrossRefPubMed Garcia D, Akl EA, Carr R, Kearon C (2013) Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review. Blood 122(5):817–824. doi:10.​1182/​blood-2013-04-496257 CrossRefPubMed

go back to reference Bezemer ID, van der Meer FJ, Eikenboom JC, Rosendaal FR, Doggen CJ (2009) The value of family history as a risk indicator for venous thrombosis. Arch Intern Med 169(6):610–615. doi:10.1001/archinternmed.2008.589 CrossRefPubMed Bezemer ID, van der Meer FJ, Eikenboom JC, Rosendaal FR, Doggen CJ (2009) The value of family history as a risk indicator for venous thrombosis. Arch Intern Med 169(6):610–615. doi:10.​1001/​archinternmed.​2008.​589 CrossRefPubMed

go back to reference Zoller B, Ohlsson H, Sundquist J, Sundquist K (2013) Familial risk of venous thromboembolism in first-, second- and third-degree relatives: a nationwide family study in Sweden. Thromb Haemost 109(3):458–463. doi:10.1160/TH12-10-0743 CrossRefPubMed Zoller B, Ohlsson H, Sundquist J, Sundquist K (2013) Familial risk of venous thromboembolism in first-, second- and third-degree relatives: a nationwide family study in Sweden. Thromb Haemost 109(3):458–463. doi:10.​1160/​TH12-10-0743 CrossRefPubMed

go back to reference Sorensen HT, Riis AH, Diaz LJ, Andersen EW, Baron JA, Andersen PK (2011) Familial risk of venous thromboembolism: a nationwide cohort study. J Thromb Haemost 9(2):320–324. doi:10.1111/j.1538-7836.2010.04129.x CrossRefPubMed Sorensen HT, Riis AH, Diaz LJ, Andersen EW, Baron JA, Andersen PK (2011) Familial risk of venous thromboembolism: a nationwide cohort study. J Thromb Haemost 9(2):320–324. doi:10.​1111/​j.​1538-7836.​2010.​04129.​x CrossRefPubMed

go back to reference Couturaud F, Leroyer C, Tromeur C, Julian JA, Kahn SR, Ginsberg JS, Wells PS, Douketis JD, Mottier D, Kearon C (2014) Factors that predict thrombosis in relatives of patients with venous thromboembolism. Blood 124(13):2124–2130. doi:10.1182/blood-2014-03-559757 CrossRefPubMedCentralPubMed Couturaud F, Leroyer C, Tromeur C, Julian JA, Kahn SR, Ginsberg JS, Wells PS, Douketis JD, Mottier D, Kearon C (2014) Factors that predict thrombosis in relatives of patients with venous thromboembolism. Blood 124(13):2124–2130. doi:10.​1182/​blood-2014-03-559757 CrossRefPubMedCentralPubMed

go back to reference Mahmoodi BK, Brouwer JL, Ten Kate MK, Lijfering WM, Veeger NJ, Mulder AB, Kluin-Nelemans HC, Van Der Meer J (2010) A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin. J Thromb Haemost 8(6):1193–1200. doi:10.1111/j.1538-7836.2010.03840.x CrossRefPubMed Mahmoodi BK, Brouwer JL, Ten Kate MK, Lijfering WM, Veeger NJ, Mulder AB, Kluin-Nelemans HC, Van Der Meer J (2010) A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin. J Thromb Haemost 8(6):1193–1200. doi:10.​1111/​j.​1538-7836.​2010.​03840.​x CrossRefPubMed

go back to reference Creinin MD, Lisman R, Strickler RC (1999) Screening for factor V Leiden mutation before prescribing combination oral contraceptives. Fertil Steril 72(4):646–651CrossRefPubMed Creinin MD, Lisman R, Strickler RC (1999) Screening for factor V Leiden mutation before prescribing combination oral contraceptives. Fertil Steril 72(4):646–651CrossRefPubMed

go back to reference Baglin T, Gray E, Greaves M, Hunt BJ, Keeling D, Machin S, Mackie I, Makris M, Nokes T, Perry D, Tait RC, Walker I, Watson H, British Committee for Standards in H (2010) Clinical guidelines for testing for heritable thrombophilia. Br J Haematol 149(2):209–220. doi:10.1111/j.1365-2141.2009.08022.x CrossRefPubMed Baglin T, Gray E, Greaves M, Hunt BJ, Keeling D, Machin S, Mackie I, Makris M, Nokes T, Perry D, Tait RC, Walker I, Watson H, British Committee for Standards in H (2010) Clinical guidelines for testing for heritable thrombophilia. Br J Haematol 149(2):209–220. doi:10.​1111/​j.​1365-2141.​2009.​08022.​x CrossRefPubMed

go back to reference Smith KJ, Monsef BS, Ragni MV (2008) Should female relatives of factor V Leiden carriers be screened prior to oral contraceptive use? A cost-effectiveness analysis. Thromb Haemost 100(3):447–452PubMed Smith KJ, Monsef BS, Ragni MV (2008) Should female relatives of factor V Leiden carriers be screened prior to oral contraceptive use? A cost-effectiveness analysis. Thromb Haemost 100(3):447–452PubMed

go back to reference Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, Writing Group for the Women’s Health Initiative I (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 288(3):321–333CrossRefPubMed Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, Writing Group for the Women’s Health Initiative I (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 288(3):321–333CrossRefPubMed

go back to reference Canonico M, Plu-Bureau G, Lowe GD, Scarabin PY (2008) Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ 336(7655):1227–1231. doi:10.1136/bmj.39555.441944.BE CrossRefPubMedCentralPubMed Canonico M, Plu-Bureau G, Lowe GD, Scarabin PY (2008) Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ 336(7655):1227–1231. doi:10.​1136/​bmj.​39555.​441944.​BE CrossRefPubMedCentralPubMed

go back to reference James AH, Jamison MG, Brancazio LR, Myers ER (2006) Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 194(5):1311–1315. doi:10.1016/j.ajog.2005.11.008 CrossRefPubMed James AH, Jamison MG, Brancazio LR, Myers ER (2006) Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 194(5):1311–1315. doi:10.​1016/​j.​ajog.​2005.​11.​008 CrossRefPubMed

go back to reference Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos A-M, Vandvik PO (2012) VTE, thrombophilia, antithrombotic therapy, and pregnancy. Chest 141(2 suppl):e691S–e736S. doi:10.1378/chest.11-2300 PubMedCentralPubMed Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos A-M, Vandvik PO (2012) VTE, thrombophilia, antithrombotic therapy, and pregnancy. Chest 141(2 suppl):e691S–e736S. doi:10.​1378/​chest.​11-2300 PubMedCentralPubMed

go back to reference Lussana F, Dentali F, Abbate R, d’Aloja E, D’Angelo A, De Stefano V, Faioni EM, Grandone E, Legnani C, Martinelli I, Simioni P, Tormene D, Italian Society for H, Thrombosis (2009) Screening for thrombophilia and antithrombotic prophylaxis in pregnancy: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res 124(5):e19–25. doi:10.1016/j.thromres.2009.06.031 CrossRefPubMed Lussana F, Dentali F, Abbate R, d’Aloja E, D’Angelo A, De Stefano V, Faioni EM, Grandone E, Legnani C, Martinelli I, Simioni P, Tormene D, Italian Society for H, Thrombosis (2009) Screening for thrombophilia and antithrombotic prophylaxis in pregnancy: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res 124(5):e19–25. doi:10.​1016/​j.​thromres.​2009.​06.​031 CrossRefPubMed

go back to reference Pabinger I, Grafenhofer H, Kaider A, Kyrle PA, Quehenberger P, Mannhalter C, Lechner K (2005) Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis. J Thromb Haemost 3(5):949–954. doi:10.1111/j.1538-7836.2005.01307.x CrossRefPubMed Pabinger I, Grafenhofer H, Kaider A, Kyrle PA, Quehenberger P, Mannhalter C, Lechner K (2005) Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis. J Thromb Haemost 3(5):949–954. doi:10.​1111/​j.​1538-7836.​2005.​01307.​x CrossRefPubMed

go back to reference Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ 3rd (2005) Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 143(10):697–706CrossRefPubMed Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ 3rd (2005) Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 143(10):697–706CrossRefPubMed

go back to reference Villani M, Tiscia GL, Margaglione M, Colaizzo D, Fischetti L, Vergura P, Grandone E (2011) Risk of obstetric and thromboembolic complications in family members of women with previous adverse obstetric outcomes carrying common inherited thombophilias. J Thromb Haemost. doi:10.1111/j.1538-7836.2011.04583.x Villani M, Tiscia GL, Margaglione M, Colaizzo D, Fischetti L, Vergura P, Grandone E (2011) Risk of obstetric and thromboembolic complications in family members of women with previous adverse obstetric outcomes carrying common inherited thombophilias. J Thromb Haemost. doi:10.​1111/​j.​1538-7836.​2011.​04583.​x

go back to reference Bain E, Wilson A, Tooher R, Gates S, Davis LJ, Middleton P (2014) Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Syst Rev 2:001689. doi:10.1002/14651858.CD001689.pub3 Bain E, Wilson A, Tooher R, Gates S, Davis LJ, Middleton P (2014) Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Syst Rev 2:001689. doi:10.​1002/​14651858.​CD001689.​pub3

go back to reference Segal JB, Brotman DJ, Necochea AJ, Emadi A, Samal L, Wilson LM, Crim MT, Bass EB (2009) Predictive value of factor V Leiden and Prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review. JAMA 301(23):2472–2485. doi:10.1001/jama.2009.853 CrossRefPubMed Segal JB, Brotman DJ, Necochea AJ, Emadi A, Samal L, Wilson LM, Crim MT, Bass EB (2009) Predictive value of factor V Leiden and Prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review. JAMA 301(23):2472–2485. doi:10.​1001/​jama.​2009.​853 CrossRefPubMed

go back to reference Bank I, Scavenius MP, Buller HR, Middeldorp S (2004) Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice. Thromb Res 113(1):7–12. doi:10.1016/j.thromres.2004.02.002 CrossRefPubMed Bank I, Scavenius MP, Buller HR, Middeldorp S (2004) Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice. Thromb Res 113(1):7–12. doi:10.​1016/​j.​thromres.​2004.​02.​002 CrossRefPubMed

go back to reference Cohn DM, Vansenne F, Kaptein AA, De Borgie CA, Middeldorp S (2008) The psychological impact of testing for thrombophilia: a systematic review. J Thromb Haemost 6(7):1099–1104. doi:10.1111/j.1538-7836.2008.03005.x CrossRefPubMed Cohn DM, Vansenne F, Kaptein AA, De Borgie CA, Middeldorp S (2008) The psychological impact of testing for thrombophilia: a systematic review. J Thromb Haemost 6(7):1099–1104. doi:10.​1111/​j.​1538-7836.​2008.​03005.​x CrossRefPubMed

go back to reference Hellmann EA, Leslie ND, Moll S (2003) Knowledge and educational needs of individuals with the factor V Leiden mutation. J Thromb Haemost 1(11):2335–2339CrossRefPubMed Hellmann EA, Leslie ND, Moll S (2003) Knowledge and educational needs of individuals with the factor V Leiden mutation. J Thromb Haemost 1(11):2335–2339CrossRefPubMed

go back to reference Duhl AJ, Paidas MJ, Ural SH, Branch W, Casele H, Cox-Gill J, Hamersley SL, Hyers TM, Katz V, Kuhlmann R, Nutescu EA, Thorp JA, Zehnder JL, Pregnancy, Thrombosis Working G (2007) Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes. American journal of obstetrics and gynecology 197(5):457e451-421. doi:10.1016/j.ajog.2007.04.022 Duhl AJ, Paidas MJ, Ural SH, Branch W, Casele H, Cox-Gill J, Hamersley SL, Hyers TM, Katz V, Kuhlmann R, Nutescu EA, Thorp JA, Zehnder JL, Pregnancy, Thrombosis Working G (2007) Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes. American journal of obstetrics and gynecology 197(5):457e451-421. doi:10.​1016/​j.​ajog.​2007.​04.​022

go back to reference Lockwood C, Wendel G, Committee on Practice Bulletins O (2011) Practice bulletin no. 124: inherited thrombophilias in pregnancy. Obstetrics and gynecology 118(3):730–740. doi:10.1097/AOG.0b013e3182310c6f Lockwood C, Wendel G, Committee on Practice Bulletins O (2011) Practice bulletin no. 124: inherited thrombophilias in pregnancy. Obstetrics and gynecology 118(3):730–740. doi:10.​1097/​AOG.​0b013e3182310c6f​

go back to reference McLintock C, Brighton T, Chunilal S, Dekker G, McDonnell N, McRae S, Muller P, Tran H, Walters BN, Young L, Councils of the Society of Obstetric Medicine of A, New Z, Australasian Society of T, Haemostasis (2012) Recommendations for the prevention of pregnancy-associated venous thromboembolism. Aust N Z J Obstet Gynaecol 52(1):3–13. doi:10.1111/j.1479-828X.2011.01357.x CrossRef McLintock C, Brighton T, Chunilal S, Dekker G, McDonnell N, McRae S, Muller P, Tran H, Walters BN, Young L, Councils of the Society of Obstetric Medicine of A, New Z, Australasian Society of T, Haemostasis (2012) Recommendations for the prevention of pregnancy-associated venous thromboembolism. Aust N Z J Obstet Gynaecol 52(1):3–13. doi:10.​1111/​j.​1479-828X.​2011.​01357.​x CrossRef

go back to reference American College of O, Gynecologists Women’s Health Care P (2013) ACOG practice bulletin no. 138: inherited thrombophilias in pregnancy. Obstet Gynecol 122(3):706–717. doi:10.1097/01.AOG.0000433981.36184.4e American College of O, Gynecologists Women’s Health Care P (2013) ACOG practice bulletin no. 138: inherited thrombophilias in pregnancy. Obstet Gynecol 122(3):706–717. doi:10.​1097/​01.​AOG.​0000433981.​36184.​4e

go back to reference Jennings I, Kitchen S, Woods TA, Preston FE (2005) Multilaboratory testing in thrombophilia through the United Kingdom National External Quality Assessment Scheme (Blood Coagulation) Quality Assurance Program. Semin Thromb Hemost 31(1):66–72. doi:10.1055/s-2005-863807 CrossRefPubMed Jennings I, Kitchen S, Woods TA, Preston FE (2005) Multilaboratory testing in thrombophilia through the United Kingdom National External Quality Assessment Scheme (Blood Coagulation) Quality Assurance Program. Semin Thromb Hemost 31(1):66–72. doi:10.​1055/​s-2005-863807 CrossRefPubMed

go back to reference Reitter-Pfoertner S, Waldhoer T, Mayerhofer M, Eigenbauer E, Ay C, Mannhalter C, Kyrle PA, Pabinger I (2013) The influence of thrombophilia on the long-term survival of patients with a history of venous thromboembolism. Thromb Haemost 109(1):79–84. doi:10.1160/TH12-05-0361 CrossRefPubMed Reitter-Pfoertner S, Waldhoer T, Mayerhofer M, Eigenbauer E, Ay C, Mannhalter C, Kyrle PA, Pabinger I (2013) The influence of thrombophilia on the long-term survival of patients with a history of venous thromboembolism. Thromb Haemost 109(1):79–84. doi:10.​1160/​TH12-05-0361 CrossRefPubMed

go back to reference Rabinovich A, Cohen JM, Prandoni P, Kahn SR (2014) Association between thrombophilia and the post-thrombotic syndrome: a systematic review and meta-analysis. J Thromb Haemost 12(1):14–23. doi:10.1111/jth.12447 CrossRefPubMed Rabinovich A, Cohen JM, Prandoni P, Kahn SR (2014) Association between thrombophilia and the post-thrombotic syndrome: a systematic review and meta-analysis. J Thromb Haemost 12(1):14–23. doi:10.​1111/​jth.​12447 CrossRefPubMed

go back to reference Rodger MA, Kahn SR, Wells PS, Anderson DA, Chagnon I, Le Gal G, Solymoss S, Crowther M, Perrier A, White R, Vickars L, Ramsay T, Betancourt MT, Kovacs MJ (2008) Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ 179(5):417–426. doi:10.1503/cmaj.080493 CrossRefPubMedCentralPubMed Rodger MA, Kahn SR, Wells PS, Anderson DA, Chagnon I, Le Gal G, Solymoss S, Crowther M, Perrier A, White R, Vickars L, Ramsay T, Betancourt MT, Kovacs MJ (2008) Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ 179(5):417–426. doi:10.​1503/​cmaj.​080493 CrossRefPubMedCentralPubMed

go back to reference Tosetto A, Iorio A, Marcucci M, Baglin T, Cushman M, Eichinger S, Palareti G, Poli D, Tait RC, Douketis J (2012) Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J Thromb Haemost 10(6):1019–1025. doi:10.1111/j.1538-7836.2012.04735.x CrossRefPubMed Tosetto A, Iorio A, Marcucci M, Baglin T, Cushman M, Eichinger S, Palareti G, Poli D, Tait RC, Douketis J (2012) Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J Thromb Haemost 10(6):1019–1025. doi:10.​1111/​j.​1538-7836.​2012.​04735.​x CrossRefPubMed

go back to reference Eichinger S, Heinze G, Jandeck LM, Kyrle PA (2010) Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model. Circulation 121(14):1630–1636. doi:10.1161/CIRCULATIONAHA.109.925214 CrossRefPubMed Eichinger S, Heinze G, Jandeck LM, Kyrle PA (2010) Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model. Circulation 121(14):1630–1636. doi:10.​1161/​CIRCULATIONAHA.​109.​925214 CrossRefPubMed

go back to reference Palareti G, Cosmi B, Legnani C, Antonucci E, De Micheli V, Ghirarduzzi A, Poli D, Testa S, Tosetto A, Pengo V, Prandoni P, Investigators D (2014) D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study. Blood 124(2):196–203. doi:10.1182/blood-2014-01-548065 CrossRefPubMed Palareti G, Cosmi B, Legnani C, Antonucci E, De Micheli V, Ghirarduzzi A, Poli D, Testa S, Tosetto A, Pengo V, Prandoni P, Investigators D (2014) D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study. Blood 124(2):196–203. doi:10.​1182/​blood-2014-01-548065 CrossRefPubMed

go back to reference Cosmi B, Legnani C, Tosetto A, Pengo V, Ghirarduzzi A, Testa S, Prisco D, Poli D, Tripodi A, Marongiu F, Palareti G (2010) Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study. Blood 115(3):481–488. doi:10.1182/blood-2009-08-237354 CrossRefPubMed Cosmi B, Legnani C, Tosetto A, Pengo V, Ghirarduzzi A, Testa S, Prisco D, Poli D, Tripodi A, Marongiu F, Palareti G (2010) Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study. Blood 115(3):481–488. doi:10.​1182/​blood-2009-08-237354 CrossRefPubMed

go back to reference Eichinger S, Minar E, Bialonczyk C, Hirschl M, Quehenberger P, Schneider B, Weltermann A, Wagner O, Kyrle PA (2003) D-dimer levels and risk of recurrent venous thromboembolism. JAMA 290(8):1071–1074. doi:10.1001/jama.290.8.1071 CrossRefPubMed Eichinger S, Minar E, Bialonczyk C, Hirschl M, Quehenberger P, Schneider B, Weltermann A, Wagner O, Kyrle PA (2003) D-dimer levels and risk of recurrent venous thromboembolism. JAMA 290(8):1071–1074. doi:10.​1001/​jama.​290.​8.​1071 CrossRefPubMed

go back to reference Castellucci LA, Cameron C, Le Gal G, Rodger MA, Coyle D, Wells PS, Clifford T, Gandara E, Wells G, Carrier M (2014) Clinical and safety outcomes associated with treatment of acute venous thromboembolism: a systematic review and meta-analysis. JAMA 312(11):1122–1135. doi:10.1001/jama.2014.10538 CrossRefPubMed Castellucci LA, Cameron C, Le Gal G, Rodger MA, Coyle D, Wells PS, Clifford T, Gandara E, Wells G, Carrier M (2014) Clinical and safety outcomes associated with treatment of acute venous thromboembolism: a systematic review and meta-analysis. JAMA 312(11):1122–1135. doi:10.​1001/​jama.​2014.​10538 CrossRefPubMed

go back to reference Cohen W, Castelli C, Suchon P, Bouvet S, Aillaud MF, Brunet D, Barthet MC, Alessi MC, Trégouët DA, Morange PE (2014) Risk assessment of venous thrombosis in families with known hereditary thrombophilia: the MARseilles-NImes prediction model. J Thromb Haemost 12(2):138–146. doi:10.1111/jth.12461 CrossRef Cohen W, Castelli C, Suchon P, Bouvet S, Aillaud MF, Brunet D, Barthet MC, Alessi MC, Trégouët DA, Morange PE (2014) Risk assessment of venous thrombosis in families with known hereditary thrombophilia: the MARseilles-NImes prediction model. J Thromb Haemost 12(2):138–146. doi:10.​1111/​jth.​12461 CrossRef

go back to reference Oger E, Lacut K, Le Gal G, Couturaud F, Abalain JH, Mercier B, Mottier D, Group ECS (2007) Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study. Thromb Res 120(2):207–214. doi:10.1016/j.thromres.2006.10.002 CrossRef Oger E, Lacut K, Le Gal G, Couturaud F, Abalain JH, Mercier B, Mottier D, Group ECS (2007) Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study. Thromb Res 120(2):207–214. doi:10.​1016/​j.​thromres.​2006.​10.​002 CrossRef

go back to reference Davis SM, Branch DW (2010) Thromboprophylaxis in pregnancy: who and how? Obstet Gynecol Clin North Am 37(2):333–343. doi:10.1016/j.ogc.2010.02.004 CrossRefPubMed Davis SM, Branch DW (2010) Thromboprophylaxis in pregnancy: who and how? Obstet Gynecol Clin North Am 37(2):333–343. doi:10.​1016/​j.​ogc.​2010.​02.​004 CrossRefPubMed

go back to reference Culwell KR, Curtis KM, del Carmen CM (2009) Safety of contraceptive method use among women with systemic lupus erythematosus: a systematic review. Obstet Gynecol 114(2 Pt 1):341–353. doi:10.1097/AOG.0b013e3181ae9c64 CrossRefPubMed Culwell KR, Curtis KM, del Carmen CM (2009) Safety of contraceptive method use among women with systemic lupus erythematosus: a systematic review. Obstet Gynecol 114(2 Pt 1):341–353. doi:10.​1097/​AOG.​0b013e3181ae9c64​ CrossRefPubMed